Diagnostic Validity of the Generalized Anxiety Disorder - 7 (GAD-7) among Pregnant Women

Qiu-Yue Zhong, Bizu Gelaye, Alan M Zaslavsky, Jesse R Fann, Marta B Rondon, Sixto E Sánchez, Michelle A Williams, Qiu-Yue Zhong, Bizu Gelaye, Alan M Zaslavsky, Jesse R Fann, Marta B Rondon, Sixto E Sánchez, Michelle A Williams

Abstract

Objective: Generalized anxiety disorder (GAD) during pregnancy is associated with several adverse maternal and perinatal outcomes. A reliable and valid screening tool for GAD should lead to earlier detection and treatment. Among pregnant Peruvian women, a brief screening tool, the GAD-7, has not been validated. This study aims to evaluate the reliability and validity of the GAD-7.

Methods: Of 2,978 women who attended their first perinatal care visit and had the GAD-7 screening, 946 had a Composite International Diagnostic Interview (CIDI). The Cronbach's alpha was calculated to examine the reliability. We assessed the criterion validity by calculating operating characteristics. The construct validity was evaluated using factor analysis and association with health status on the CIDI. The cross-cultural validity was explored using the Rasch Rating Scale Model (RSM).

Results: The reliability of the GAD-7 was good (Cronbach's alpha = 0.89). A cutoff score of 7 or higher, maximizing the Youden Index, yielded a sensitivity of 73.3% and a specificity of 67.3%. One-factor structure of the GAD-7 was confirmed by exploratory and confirmatory factor analysis. Concurrent validity was supported by the evidence that higher GAD-7 scores were associated with poor self-rated physical and mental health. The Rasch RSM further confirmed the cross-cultural validity of the GAD-7.

Conclusion: The results suggest that the Spanish-language version of the GAD-7 may be used as a screening tool for pregnant Peruvian women. The GAD-7 has good reliability, factorial validity, and concurrent validity. The optimal cutoff score obtained by maximizing the Youden Index should be considered cautiously; women who screened positive may require further investigation to confirm GAD diagnosis.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Receiver Operating Characteristics (ROC) Curves…
Fig 1. Receiver Operating Characteristics (ROC) Curves of Generalized Anxiety Disorder 7-Item (GAD-7) Scores.

References

    1. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed Arlington: American Psychiatric Association, 2013.
    1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092–1097.
    1. The American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111(4):1001–1020. 10.1097/AOG.0b013e31816fd910
    1. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007;20(3):189–209.
    1. de Paz NC, Sánchez SE, Huaman LE, Chang GD, Pacora PN, Garcia PJ, et al. Risk of placental abruption in relation to maternal depressive, anxiety and stress symptoms. J Affect Disord 2011;130(1):280–284.
    1. Huizink AC, Mulder EJ, Robles de Medina PG, Visser GH, Buitelaar JK. Is pregnancy anxiety a distinctive syndrome? Early Hum Dev 2004;79(2):81–91.
    1. Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh B, Buitelaar JK, Visser GH. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev 2002;70(1):3–14.
    1. Qiu CF, Williams MA, Calderon-Margalit R, Cripe SM, Sorensen TK. Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. Am J Hypertens 2009;22(4):397–402. 10.1038/ajh.2008.366
    1. Ding X, Wu Y, Xu S, Zhu R, Jia X, Zhang S, et al. Maternal anxiety during pregnancy and adverse birth outcomes: A systematic review and meta-analysis of prospective cohort studies. J Affect Disord 2014;159:103–110. 10.1016/j.jad.2014.02.027
    1. Sutter-Dallay A, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry 2004;19(8):459–463.
    1. Kertz SJ, Bigda-Peyton J, Bjorgvinsson T. Validity of the Generalized Anxiety Disorder-7 Scale in an Acute Psychiatric Sample. Clin Psychol Psychot 2013;20(5):456–464. 10.1002/cpp.1802
    1. Rubertsson C, Hellström J, Cross M, Sydsjö G. Anxiety in early pregnancy: prevalence and contributing factors. Arch Women Ment Hlth 2014:1–8.
    1. Austin MP. Antenatal screening and early intervention for “perinatal” distress, depression and anxiety: where to from here? Arch Women Ment Hlth 2004;7(1):1–6.
    1. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Wolfgang H, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008;46(3):266–274. 10.1097/MLR.0b013e318160d093
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2197–2223. 10.1016/S0140-6736(12)61689-4
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed Arlington: American Psychiatric Association, 1994.
    1. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146(5):317–325.
    1. Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiat 2008;30(3):191–199. 10.1016/j.genhosppsych.2008.01.001
    1. Kessler RC, Üstün TB. The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI). Int J Method Psych 2004;13(2):93–121.
    1. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994;28(1):57–84.
    1. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Brit J Psychiat 1991;159(5):645–653.
    1. Kessler RC, Üstün TB. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press, 2008.
    1. Kessler RC, Brandenburg N, Lane M, Roy-Byrne P, Stang PD, Stein DJ, et al. Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med 2005;35(7):1073–1082.
    1. Youden W. Index for rating diagnostic tests. Cancer 1950;3(1):32–35.
    1. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom 2005;47(4):458–472.
    1. Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York: Oxford University Press, 2003.
    1. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983;39(1):207–215.
    1. Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas 1960;20:141–151.
    1. Brown TA. Confirmatory factor analysis for applied research. New York: Guilford Press, 2006.
    1. Bond TG, Fox CM. Applying the Rasch model: Fundamental measurement in the human sciences. United Kingdom: Psychology Press, 2013. 10.1186/1471-2377-13-78
    1. Andrich D. A rating formulation for ordered response categories. Psychometrika 1978;43(4):561–573.
    1. Andrich D. Application of a psychometric rating model to ordered categories which are scored with successive integers. Appl Psych Meas 1978;2(4):581–594.
    1. Lamoureux EL, Tee HW, Pesudovs K, Pallant JF, Keeffe JE, Rees G. Can clinicians use the PHQ-9 to assess depression in people with vision loss? Optom Vis Sci 2009;86(2):139–145. 10.1097/OPX.0b013e318194eb47
    1. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: MESA Press, 1993.
    1. Forkmann T, Gauggel S, Spangenberg L, Brähler E, Glaesmer H. Dimensional assessment of depressive severity in the elderly general population: Psychometric evaluation of the PHQ-9 using Rasch Analysis. J Affect Disord 2013.
    1. Zhong QY, Gelaye B, Fann JR, Sánchez SE, Williams MA. Cross-cultural validity of the Spanish version of PHQ-9 among pregnant Peruvian women: A Rasch Item Response Theory analysis. J Affect Disord 2014;158:148–153. 10.1016/j.jad.2014.02.012
    1. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Care Res 2007;57(8):1358–1362.
    1. Andrich D. The Rasch model explained Applied Rasch measurement: A book of exemplars. New York: Springer, 2005.
    1. Adams RJ, Wu ML, Wilson M. The Rasch rating model and the disordered threshold controversy. Educ Psychol Meas 2012;72(4):547–573.
    1. Muraki E. A generalized partial credit model: Application of an EM algorithm. Appl Psych Meas 1992;16(2):159–176.
    1. Li Y, Baser R. Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient-reported outcomes assessments. Stat Med 2012;31(18):2010–2026. 10.1002/sim.4475
    1. Tijdink J, Smulders Y, Vergouwen A, de Vet H, Knol D. The assessment of publication pressure in medical science; validity and reliability of a Publication Pressure Questionnaire (PPQ). Qual Life Res 2014:1–8. 10.1007/s11136-014-0769-6
    1. Baker FB. The basics of item response theory. ERIC, 2001. Retrieved from .
    1. Sidik SM, Arroll B, Goodyear-Smith F. Validation of the GAD-7 (Malay version) among women attending a primary care clinic in Malaysia. J Prim Health Care 2012;4(1): 5–11.
    1. García-Campayo J, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes 2010;8(8).
    1. Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, et al. Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depen 2012;125(1):37–42. 10.1016/j.drugalcdep.2012.03.011
    1. Donker T, van Straten A, Marks I, Cuijpers P. Quick and easy self-rating of Generalized Anxiety Disorder: Validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res 2011;188(1):58–64. 10.1016/j.psychres.2011.01.016
    1. Abbey CK, Eckstein MP, Boone JM. Estimating the relative utility of screening mammography. Med Decis Making 2013;33(4):510–520. 10.1177/0272989X12470756
    1. Simpson W, Glazer M, Michalski N, Steiner M, Frey BN. Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatry 2014;59(8):434–440.
    1. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins, 2008.
    1. Gelaye B, Williams MA, Lemma S, Deyessa N, Bahretibeb Y, Shibre T, et al. Diagnostic validity of the Composite International Diagnostic Interview (CIDI) depression module in an east African population. Int J Psychiat Med 2013;46(4):387–405.
    1. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, et al. Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMH-CIDI). Int J Method Psych 2004;13(2):122–139.
    1. Kessler RC, Andrews G, Mroczek D, Üstün B, Wittchen HU. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Method Psych 1998;7(4):171–185.
    1. Bar-Shai M, Gott D, Kreinin I, Marmor S. Atypical presentations of pregnancy-specific generalized anxiety disorders in women without previous psychiatric background. Psychosomatics. Retrieved from .
    1. Shear MK, Mammen O. Anxiety disorders in pregnant and postpartum women. Psychopharmacol Bull 1995;31(4):693
    1. Vythilingum B. Anxiety disorders in pregnancy. Curr Psychiatry Rep 2008;10(4):331–335.
    1. Adewuya A, Ola B, Aloba O, Mapayi B. Anxiety disorders among Nigerian women in late pregnancy: a controlled study. Arch Womens Ment Health 2006;9(6):325–328.
    1. Orr ST, Reiter JP, Blazer DG, James SA. Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. Psychosom Med 2007;69(6):566–570.
    1. Van den Bergh B. The influence of maternal emotions during pregnancy on fetal and neonatal behavior. J Prenat Perinat Psychol Health 1990; 5(2).
    1. Burstein I, Kinch R, Stern L. Anxiety, pregnancy, labor, and the neonate. Am J Obstet Gynecol 1974;118(2):195–199.
    1. Pompili M. Suicide: a global perspective. Sharjah: Bentham Science Publishers, 2012.
    1. Garcia-Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH. Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence. The Lancet 2006;368(9543):1260–1269.
    1. Perales MT, Cripe SM, Lam N, Sánchez SE, Sánchez E, Williams MA. Prevalence, types, and pattern of intimate partner violence among pregnant women in Lima, Peru. Violence Against Wom 2009;15(2):224–250. 10.1177/1077801208329387
    1. McFall RM, Treat TA. Quantifying the information value of clinical assessments with signal detection theory. Annu Rev Psychol 1999;50(1):215–241.
    1. Smits N, Smit F, Cuijpers P, De Graaf R. Using decision theory to derive optimal cut-off scores of screening instruments: an illustration explicating costs and benefits of mental health screening. Int J Method Psych 2007;16(4):219–229. 10.1002/mpr.230
    1. Kraemer HC. Evaluating medical tests: Objective and quantitative guidelines. Newbury Park: Sage publications, 1992.
    1. Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F, Gardner W, et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiat 2005;62(12):1332–1341.
    1. Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010;303(19):1921–1928. 10.1001/jama.2010.608
    1. Portman ME, Starcevic V, Beck AT. Challenges in assessment and diagnosis of generalized anxiety disorder. Psychiatr Ann 2011;41(2):79–85.
    1. García-Campayo J, Zamorano E, Ruiz MA, Pérez-Páramo M, López-Gómez V, Rejas J. The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice. Health Qual Life Outcomes 2012;10:114 10.1186/1477-7525-10-114
    1. Wetzel E, Carstensen CH. Reversed Thresholds in Partial Credit Models A Reason for Collapsing Categories? Assessment 2014. Retrieved from .
    1. Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disorders 2011;128(3):277–286. 10.1016/j.jad.2010.07.010

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir